STUB vs GENI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

STUB

56.1
AI Score
VS
GENI Wins

GENI

59.9
AI Score

Investment Advisor Scores

STUB

56score
Recommendation
HOLD

GENI

60score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric STUB GENI Winner
Revenue 1.75B 669.49M STUB
Net Income -1.91B -111.58M GENI
Net Margin -109.2% -16.7% GENI
Operating Income -1.34B -151.33M GENI
ROE -161.0% -15.4% GENI
ROA -37.7% -9.9% GENI
Total Assets 5.05B 1.13B STUB
Cash 1.24B 280.56M STUB
Current Ratio 1.04 1.56 GENI
Free Cash Flow 191.18M 64.54M STUB

Relative Price Performance (Last 90 Days)

STUB 1M: -30.2% · 3M: +17.7% GENI 1M: +10.0% · 3M: +62.5%

Current Technical Phase

STUB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 41.2 · Price: $8.98

GENI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (15.8% over 20 days), RSI 60

RSI (14): 59.6 · Price: $7.07

Fundamentals Snapshot

Metric STUB GENI
Market Cap
Forward P/E 11.9 7.3
Trailing P/E
Revenue (TTM)
Revenue Growth 0.1% 0.3%
Gross Margin 0.8% 0.2%
Operating Margin 0.1% -0.2%
EPS -5.18 -0.62
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, GENI is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.